Latest filing published 26 May 2022 for EUROBIO-SCIENTIFIC, €22.2M.
Filing timeline
BuySaleInsider track record
Jean-Michel CARLE GRANDMOUGIN: trading record in brief
Jean-Michel CARLE GRANDMOUGIN is a declared insider of Eurobio-Scientific (chief executive), with filings sourced from AMF. Between 4 May 2021 and 18 May 2022, the trades on record add up to 8 filings.
Every open-market trade on record is a sale: 6 sales worth €16.6M. In 2022 alone, the filings show no purchases and 4 sales.
On 26 May 2022 came the latest disclosure, a transaction for €22.2M in Eurobio-Scientific. Between a trade and the moment it shows up on AMF, the median delay is 5 days. For comparison, MAR article 19 gives managers three business days to notify a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by AMF and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jean-Michel CARLE GRANDMOUGIN
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 876,909 shares@ €25.2897.5% of flowActionHors plateforme de négociationISIN FR00132409342022DD843698
- 55,380 shares0ActionHors plateforme de négociationISIN FR00132409342022DD832636
- 4,385 shares@ €28.60020.6% of flowActionEuronext Growth ParisISIN FR00132409342022DD814041
- 1,402 shares@ €20.00540.1% of flowActionEuronext Growth ParisISIN FR00132409342021DD759103
- 20,500 shares@ €20.46451.8% of flowActionEuronext Growth ParisISIN FR00132409342021DD744964
5 of 5 declarations